TP53 and non-small cell lung carcinoma: We carried out a p53 knockdown experiment in CB11-treated NSCLC cells, and the knockdown prevented the decrease in cell viability and the increase of LDH release caused by CB11 when compared to control cells (Fig. 3i, j).